508 related articles for article (PubMed ID: 30481763)
1. The Present Status and Future of Barrett's Esophageal Adenocarcinoma in Japan.
Nishi T; Makuuchi H; Ozawa S; Shimada H; Chino O
Digestion; 2019; 99(2):185-190. PubMed ID: 30481763
[TBL] [Abstract][Full Text] [Related]
2. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
3. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
4. Management of Barrett's esophageal carcinoma.
Miyazaki T; Inose T; Tanaka N; Yokobori T; Suzuki S; Ozawa D; Sohda M; Nakajima M; Fukuchi M; Kato H; Kuwano H
Surg Today; 2013 Apr; 43(4):353-60. PubMed ID: 23283352
[TBL] [Abstract][Full Text] [Related]
5. Review article: Barrett's oesophagus and carcinoma in Japan.
Hongo M
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
[TBL] [Abstract][Full Text] [Related]
6. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
8. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
De Backer AI; De Schepper AM; Pelckmans P
Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
[TBL] [Abstract][Full Text] [Related]
9. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.
Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L
Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of Barrett's esophagus--comparison of Japan and the West].
Hanai M; Kusano M; Kawamura O; Shimoyama Y; Maeda M
Nihon Rinsho; 2005 Aug; 63(8):1333-9. PubMed ID: 16101218
[TBL] [Abstract][Full Text] [Related]
12. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion.
Horii T; Koike T; Abe Y; Kikuchi R; Unakami H; Iijima K; Imatani A; Ohara S; Shimosegawa T
Scand J Gastroenterol; 2011 Jun; 46(6):710-9. PubMed ID: 21446884
[TBL] [Abstract][Full Text] [Related]
13. [Clinical outline of Barrett's esophagus].
Kuwano H; Sohda M; Kato H; Miyazaki T; Kimura H
Nihon Rinsho; 2005 Aug; 63(8):1372-8. PubMed ID: 16101224
[TBL] [Abstract][Full Text] [Related]
14. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
16. Advances in Barrett's esophagus and esophageal adenocarcinoma.
Shaheen NJ
Gastroenterology; 2005 May; 128(6):1554-66. PubMed ID: 15887151
[TBL] [Abstract][Full Text] [Related]
17. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
18. [Preface: Recent perspectives of the Barrett's esophagus].
Hongo M
Nihon Rinsho; 2005 Aug; 63(8):1319-22. PubMed ID: 16101216
[TBL] [Abstract][Full Text] [Related]
19. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
Solaymani-Dodaran M; Logan RF; West J; Card T
Am J Gastroenterol; 2005 Dec; 100(12):2616-21. PubMed ID: 16393209
[TBL] [Abstract][Full Text] [Related]
20. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]